ALLMedicine™ Hyperbilirubinemia Center
Research & Reviews 1,457 results
https://doi.org/10.1007/s00431-022-04536-2 10.1002/14651858.CD003248.pub3 10.1542/peds.2015-3236 10.1097/ANC.0b013e3182761246 10.1097/AOG.0000000000003172 10.1016/j.earlhumdev.2019.104948 10.1055/s-0039-1695799 10.1111/jmwh.13075 10.2298/vsp1410907m 10.1016/j.endonu.2016.04.010 10.1002/ijgo.13615 10.1111/birt.12398 10.1542/peds.114.1.297 10.1097/AOG.0000000000004167 10.1542/peds.2004-1773 10.1111/jjns.12372 10.1016/j.jpeds.2020.05.018 10.1016/j.ejogrb.2021.04.038 10.1111/dme.13962 10.1016/j.ejogrb.2020.03.019 10.2337/dc20-S014 10.5603/GP.a2020.0096 10.1080/14767058.2021.1946785 10.1155/2016/9648798 10.1007/s11892-013-0457-x
European Journal of Pediatrics; Pan S, Lu Q et. al.
Jun 26th, 2022 - The purpose of the study is to investigate the effects of delayed cord clamping on bilirubin levels and phototherapy rates in neonates of diabetic mothers. This was a prospective study that enrolled pregnant women without pregnancy complications a...
https://doi.org/10.1111/bcp.15445
British Journal of Clinical Pharmacology; Faragalla K, Lau H et. al.
Jun 23rd, 2022 - Ductopenia is often regarded as a chronic process where ≥50% of portal tracts lack bile ducts, which is also known as vanishing bile duct syndrome (VBDS). One etiology is drug-induced liver injury. Cloxacillin, an anti-staphylococcal penicillin, t...
https://doi.org/10.1186/s12887-022-03412-0 10.1182/blood.V71.5.1201.1201 10.1038/nrc1164 10.1093/jnci/djh287 10.1016/j.jpeds.2005.03.008 10.1203/01.PDR.0000057983.95219.0B 10.1056/NEJMct0708376 10.1542/peds.75.2.387 10.1203/00006450-199811000-00027 10.1111/j.1651-2227.2010.01898.x 10.1258/acb.2008.008076 10.1016/j.earlhumdev.2013.09.013 10.1016/j.pedneo.2018.03.004 10.1016/j.ejmhg.2011.11.003 10.1016/j.mrgentox.2009.03.008 10.18869/acadpub.ibj.21.3.182 10.1002/em.2860010404 10.1055/s-0029-1243311 10.1074/jbc.M001281200 10.1136/adc.2009.179275 10.1002/cncr.11114 10.1001/archderm.142.12.1599 10.1542/peds.2015-1353 10.1542/peds.2015-1354 10.1007/BF00052666 10.1002/ijc.33376 10.1111/apa.14436
BMC Pediatrics; Sabzevari F, Sinaei R et. al.
Jun 22nd, 2022 - Neonatal phototherapy (NNPT) has long been used as an effective and relatively safe method of treating neonatal hyperbilirubinemia. Considering the subsequent evidence of long-term impacts of NNPT such as malignancies, this study was conducted to ...
https://doi.org/10.1186/s12909-022-03546-w 10.1080/17474086.2017.1331124 10.1053/j.semperi.2011.02.013.PMID:21641492) 10.4103/ajts.AJTS_106_17 10.1016/j.jpeds.2004.01.054 10.11565/arsmed.v36i2.154 10.1136/bmj.1.5955.447 10.1023/A:1009869328173 10.1136/archdischild-2018-315221 10.1542/peds.114.1.297 10.1542/peds.2006-2910 10.33588/fem.8S02.117 10.22201/facmed.20075057e.2019.32.18133 10.1542/neo.4-7-e169 10.1016/j.amjsurg.2014.05.034 10.1053/j.nainr.2010.12.012 10.1053/j.semperi.2011.02.013 10.1097/ACM.0000000000000800
BMC Medical Education; Calderón MJM, Pérez SIA et. al.
Jun 21st, 2022 - Exchange transfusion is the treatment of choice for patients with severe hyperbilirubinemia who do not respond to phototherapy. This procedure is highly complex and requires substantial expertise to perform, however it´s not done frequently enough...
https://doi.org/10.1016/j.transproceed.2022.03.024
Transplantation Proceedings; Fernandes MR, Nacif LS et. al.
Jun 18th, 2022 - The small-for-size syndrome (SFSS) is characterized by prolonged hyperbilirubinemia, coagulopathy, and/or encephalopathy caused by a small liver graft that cannot sustain the metabolic demands of the recipient after a partial liver transplant (PLT...
Guidelines 3 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.
Sep 30th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...
https://doi.org/10.1542/peds.2011-1494
Pediatrics Bhutani VK, et. al.
Sep 29th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...
https://doi.org/10.1111/j.1751-486X.2010.01516.x
Nursing for Women's Health;
Feb 9th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,
Drugs 39 results see all →
Clinicaltrials.gov 126 results
https://clinicaltrials.gov/ct2/show/NCT04962113
May 27th, 2022 - The study was conducted as a randomized controlled study to determine effect of tube bathing on skin and bilirubin levels in infants undergoing tunnel and LED of phototherapy. The population of the study consisted of term babies with the diagnosis...
https://clinicaltrials.gov/ct2/show/NCT05163145
May 20th, 2022 - Neonates with prematurity,gastrointestinal dysfunction and very low birth weights are often intolerant to oral feeding.In such infants,the provision of nutrients via parenteral nutrition (PN)becomes necessary for short term survival,as well as lon...
https://clinicaltrials.gov/ct2/show/NCT03527537
May 13th, 2022 - Gestational diabetes mellitus (GDM) affects 5-8% of pregnant women, many of whom will require treatment beyond diet and exercise. Despite this high prevalence, there is no consensus regarding the glycemic threshold for conversion from diet to medi...
https://clinicaltrials.gov/ct2/show/NCT04638075
May 12th, 2022 - Supplemental feedings in the neonatal intensive care unit (NICU) are common due to the separation of mother and neonate and/or complex medical issues that make direct breastfeeding difficult. The Supplemental Nursing System (SNS) is utilized infre...
https://clinicaltrials.gov/ct2/show/NCT05121311
May 3rd, 2022 - Neonatal jaundice is common and mostly transient without need for intervention. To identify infants at risk of bilirubin toxicity, bilirubin is measured several times after birth and before discharge home. As the peak bilirubin concentrations are ...
News 132 results
https://www.onclive.com/view/frontline-lenvatinib-tace-improves-os-in-advanced-hcc
Jan 22nd, 2022 - Transarterial chemoembolization (TACE) plus lenvatinib (Lenvima) led to a significant improvement in overall survival (OS) vs lenvatinib alone as frontline therapy in patients with advanced hepatocellular carcinoma (HCC), according to findings fro...
https://www.onclive.com/view/challenges-in-early-detection-of-gvhd
Jan 21st, 2022 - Yi-Bin Chen, MD: A lot of research has gone into early detection of graft-vs-host disease [GVHD]. It’s difficult to detect graft-vs-host disease early because we’d all admit that the immune response takes weeks before we see the manifestation. Why...
https://www.medscape.com/viewarticle/962798
Nov 11th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando...
https://www.mdedge.com/hematology-oncology/article/248519/gastrointestinal-cancer/chemotherapy-folfox-superior-tace-liver
Pam Harrison
Nov 10th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando.
https://www.onclive.com/view/expert-recaps-advances-in-aml
Oct 6th, 2021 - Rami S. Komrokji, MD Now that physicians have access to novel therapies for patients with acute myeloid leukemia (AML) following a 30-year gap in therapeutic development, physicians must now aim to understand their optimal placement in treatment,...